Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
+6.12%
$5.48
99% positive prob.
5-Day Prediction
+12.76%
$5.82
99% positive prob.
20-Day Prediction
+11.91%
$5.77
94% positive prob.
| Quarter | Signal | 1D Return | 5D Return | 20D Return | Confidence | Actual 5D |
|---|---|---|---|---|---|---|
| Q2 2026 | BUY | +6.12% | +12.76% | +11.91% | 98.5% | Pending |
| Q1 2026 | SELL | -6.34% | -6.90% | -10.15% | 100.0% | -10.54% |
| Q4 2025 | SELL | -4.87% | -5.92% | -7.70% | 99.8% | -14.69% |
SEC 8-K filings with transcript text
Aug 10, 2026 · 99% conf.
1D
+6.12%
$5.48
5D
+12.76%
$5.82
20D
+11.91%
$5.77
2 ef20079831_ex99-1.htm
Exhibit 99.1
Nu Skin Enterprises Reports Second Quarter Results
PROVO, Utah — Aug. 10, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced second quarter results.
Executive Summary
Q2 2026 vs. Prior-year Quarter
Revenue
$320.1 million; (17.1)%
• (1.0)% FX impact or $(4.0) million
Earnings Per Share (EPS)
$(5.14) or $0.20 excluding non-cash impairment and non-cash tax charges compared to $0.43
Customers
660,037; (14)%
Paid Affiliates
120,291; (8)%
Sales Leaders
26,998; (9)%
“We continue to make progress toward our long-term strategy with the continued rollout of Prysm iO and preparations for the formal launch of India,” said Ryan Napierski, Nu Skin president and CEO. “As these initiatives are taking hold, we are incorporating valuable learnings to strengthen our plans moving forward. At the same time, we are re-aligning our organizational resources to better position the business to drive sustainable, long-term value for our shareholders.”
Nu Skin Enterprises Reports Second Quarter 2026 Financial Results
page 2
Q2 2026 Year-over-year Operating Results
Revenue
$320.1 million compared to $386.1 million
• (1.0)% FX impact or $(4.0) million
Gross Margin
68.2% compared to 68.8%
• Nu Skin business was 77.7% compared to 77.5%
Selling Expenses
33.7% compared to 33.2%
• Nu Skin business was 39.8% compared to 40.0%
G&A Expenses
28.4% compared to 27.6%
Operating Margin
(18.5)% or 6.1% excluding non-cash impairment charge compared to 8.0%
Interest Expense
$3.3 million compared to $2.5 million
Other Income (Expense)
$(0.5) million compared to $(0.8) million
Income Tax Rate
(295.4)% or 36.6% excluding non-cash tax charge compared to 23.0%
EPS
$(5.14) or $0.20 excluding non-cash impairment and non-cash tax charges compared to $0.43
Stockholder Value
Dividend Payments
$2.9 million
Stock Repurchases
$0.0 million
• $137.3 million remaining in authorization
Q3 and Full-year 2026 Outlook
Q3 2026 Revenue
$310 to $340 million; (15)% to (7)%
• Approximately (3) to (2)% FX impact
$0.00 to $0.09 or $0.10 to $0.20 on an adjusted basis
2026 Revenue
$1.28 to $1.35 billion; (14)% to (9)%
• Approximately (1)% FX impact
($4.90) to ($4.73) or $0.70 to $0.90 on an adjusted basis
“We delivered adjusted earnings per share near the midpoint of our guidance, reflecting our ongoing focus on profitability and disciplined execution,” said Chelsea Lantz, interim chief financial officer. “Based on our first-half performance and outlook for the rest of the year, we are updating our annual guidance to revenue of $1.28 billion to $1.35 billion and adjusted earnings per share of $0.70 to $0.90. For the third quarter, we expect revenue between $310 million and $340 million, with adjusted earnings per share in the range of $0.10 to $0.20.”
Nu Skin Enterprises Reports Second Quarter 2026 Financial Results
page 3
Conference Call
The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company's website at ir.nuskin.com. A replay of the webcast will be available on the same page through Aug. 24, 2026.
About Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.
Important Information Regarding Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company’s current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements of management’s expectations regarding the company’s performance, growth, initiatives, shareholder value, Prysm launch and its timing, and India expansion; projections regarding revenue, expenses, margins, tax rates, earnings per share, foreign currency fluctuations, uses of cash, financial p
May 7, 2026 · 100% conf.
1D
-6.34%
$6.57
Act: +0.71%
5D
-6.90%
$6.54
Act: -10.54%
20D
-10.15%
$6.31
Act: -23.50%
2 ef20072663_ex99-1.htm
Exhibit 99.1
Nu Skin Enterprises Reports First Quarter Results
PROVO, Utah — May 7, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter revenue results within its guidance range.
Executive Summary
Q1 2026 vs. Prior-year Quarter
Revenue
$320.6 million; (12.0)%
• +1.1% FX impact or $3.9 million
Earnings Per Share (EPS)
$0.04 or $0.14 excluding certain charges compared to $2.14 or $0.23 excluding one-time gain from Mavely sale and other charges
Customers
669,535; (14)%
Paid Affiliates
120,850; (8)%
Sales Leaders
26,915; (13)%
“We delivered first quarter revenue in line with our expectations and made further progress in our strategic priorities while operating in a volatile environment,” said Ryan Napierski, Nu Skin president and CEO. “As we move through 2026, we are focused on empowering our sales leaders to scale our intelligent wellness platform with our latest innovation, Prysm iO™, ahead of our full consumer rollout in the second half. We also continue to invest in laying the groundwork to expand our presence in emerging markets, including the formal launch of India anticipated in late 2026, while continuing to improve our operational discipline to return value to shareholders.
“We are encouraged by early signs of improving paid affiliates and new sales leader development in several markets as our leaders begin integrating Prysm iO into their businesses and continue to build upon our leading anti-aging Tru Face® brand. We are focused on partnering with our sales force on leveraging the proprietary nutritional health biomarker tracking from Prysm iO to expand the channel as we prepare to drive customer subscriptions for our wellness products. While these initiatives will take time to develop, we remain confident that they will increase sales leader engagement and expand our global reach over time to drive the next phase of growth for Nu Skin.”
Nu Skin Enterprises Reports First Quarter 2026 Financial Results
page 2
Q1 2026 Year-over-year Operating Results
Revenue
$320.6 million compared to $364.5 million
• +1.1% FX impact or $3.9 million
Gross Margin
66.9% or 67.9% excluding certain charges compared to 67.8%
• Nu Skin business was 76.9% compared to 76.7%
Selling Expenses
34.3% compared to 32.5%
• Nu Skin business was 40.5% compared to 38.7%
G&A Expenses
30.7% or 29.9% excluding certain charges compared to 31.1% or 28.9% excluding certain charges
Impairment Expenses
$1.8 million impairment compared to $25.1 million impairment
Operating Margin
1.3% or 3.6% excluding certain charges compared to (2.7)% or 6.4% excluding impairment and other charges
Interest Expense
$4.3 million compared to $3.3 million
Other Income (Expense)
$2.8 million compared to $(28.4) million
• Prior year reflects $28.1 million unrealized loss on investment
Income Tax Rate
29.4% compared to 20.1%
EPS
$0.04 or $0.14 excluding certain charges compared to $2.14 or $0.23 excluding one-time gain from Mavely sale and other charges
Stockholder Value
Dividend Payments
$2.9 million
Stock Repurchases
$5.0 million
• $137.3 million remaining in authorization
Q2 and Full-year 2026 Outlook
Q2 2026 Revenue
$330 to $360 million; (15)% to (7)%
• Approximately 0% FX impact
$0.15 to $0.25
2026 Revenue
$1.35 to $1.50 billion; (9)% to 1%
• Approximately (1)% FX impact
$0.70 to $1.10 or $0.80 to $1.20 excluding certain charges
“In addition to delivering on revenue and adjusted earnings, we returned $8 million to shareholders in the form of dividends and share repurchases,” said Chelsea Lantz, interim chief financial officer. “We were also able to refinance our debt, extending our liquidity as we invest in growth initiatives and navigate market volatility while executing on our strategy. We are maintaining our annual guidance for 2026 on an adjusted basis. For the second quarter, we project revenue between $330 million and $360 million, with earnings per share in the range of $0.15 to $0.25.”
Nu Skin Enterprises Reports First Quarter 2026 Financial Results
page 3
Conference Call
The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company’s website at ir.nuskin.com. A replay of the webcast will be available on the same page through May 21, 2026.
About Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellnes
Feb 12, 2026 · 100% conf.
1D
-4.87%
$9.71
Act: -18.12%
5D
-5.92%
$9.61
Act: -14.69%
20D
-7.70%
$9.42
Act: -29.77%
false000102156100010215612026-02-122026-02-12
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
February 12, 2026
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
Delaware
001-12421
87-0565309
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification Number)
75 West Center Street
Provo, Utah 84601
(Address of principal executive offices and zip code)
(801) 345-1000
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $.001 par value
NUS
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Condition.
On February 12, 2026, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three-month and annual periods ended December 31, 2025, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report.
The information furnished pursuant to this Item 2.02 and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits.
99.1
Nu Skin Enterprises’ press release dated February 12, 2026, regarding financial results for the three-month and annual periods ended December 31, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
(Registrant)
/s/ James D. Thomas
James D. Thomas
Chief Financial Officer
Date: February 12, 2026
This page provides Nu Skin Enterprises Inc. (NUS) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on NUS's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.